Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Jun;105(11):842-847.
doi: 10.1136/heartjnl-2018-314077. Epub 2019 Jan 19.

Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific

Eugene S J Tan  1 , Wan Ting Tay  2 , Tiew-Hwa Katherine Teng  2 , David Sim  2   3 , Kui Toh Gerard Leong  4 , Poh Shuan Daniel Yeo  5 , Hean Yee Ong  6 , Fazlur Jaufeerally  3   7 , Tze Pin Ng  8 , Katrina Poppe  9 , Mayanna Lund  10 , Gerard Devlin  11 , Richard W Troughton  12 , Lieng Hsi Ling  1 , Arthur Mark Richards  1   12   13 , Robert N Doughty  9 , Carolyn S P Lam  2   3   14
Affiliations
Comparative Study

Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific

Eugene S J Tan et al. Heart. 2019 Jun.

Abstract

Objective: Ethnic differences in the prevalence of atrial fibrillation (AF) in heart failure (HF) remain unclear. We compared the prevalence and clinical correlates of AF among different ethnicities in an Asian-Pacific population with HF.

Methods: Patients with validated HF were prospectively studied across Singapore and New Zealand (NZ).

Results: Among 1746 patients with HF (62% Asian, 26% women, mean age 66 (SD 13) years, mean ejection fraction (EF) 37 (SD 16%), 39% had AF. The prevalence of AF was markedly lower in Singapore-Asians than NZ-Europeans (24% vs 63%; p<0.001), even after adjusting for age, clinical and echocardiographic covariates, regardless of EF group (pinteraction for EF=0.39). Patients with AF were older, had higher body mass index and were more likely to have a history of hypertension, stroke, peripheral vascular disease, renal disease, chronic respiratory disease and increased alcohol intake, but less likely to have diabetes. Clinical correlates were similar for Asians and NZ-Europeans, except diabetes: Asian diabetic patients with HF had less AF compared with Asian patients without diabetes (OR 0.66, 95% CI 0.50 to 0.88), whereas among NZ-Europeans there was no significant association between diabetes and AF (OR 1.22, 95% CI 0.85 to 1.75) (pinteraction for ethnicity=0.01). AF was associated with a higher crude composite outcome of mortality and HF hospitalisations at 2 years (HR 1.19, 95% CI 1.02 to 1.38).

Conclusion: There is a strikingly lower prevalence of AF among Asian compared with NZ-European patients with HF. The underlying mechanisms for the lower prevalence of AF among Asians, particularly in the presence of diabetes, deserve further study.

Trial registration number: ACTRN12610000374066.

Keywords: atrial fibrillation; diabetes; heart failure.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CSPL reports grants from National Medical Research Council of Singapore during the course of the study, research support from Boston Scientific, Bayer, Thermofisher, Medtronic, Vifor Pharma; personal fees from consultation for Bayer, Novartis, Takeda, Merck, AstraZeneca, Janssen Research & Development, Menarini, Boehringer Ingelheim, Abbott Diagnostics, Corvia, Stealth BioTherapeutics, Roche and Amgen, outside the submitted work; RT reports grants from Roche Diagnostics and Merck outside the submitted work; RND reports grants from Health Research Council of NZ, New Zealand Heart Foundation and Auckland Medical Research Foundation, during the conduct of the study; AMR reports grants from Government and Charitable Funding Bodies, non-financial support from Roche Diagnostics during the conduct of the study; personal fees and non-financial support from Roche Diagnostics outside the submitted work; KP reports grants from Heart Foundation of New Zealand and Health Research Council of New Zealand, outside the submitted work; ML reports grants from Health Research Council, Auckland Medical Research Foundation, and New Zealand Lottery Grants Board, during the conduct of the study; VAC reports grants from Health Research Council of New Zealand, during the conduct of the study.

Comment in

Publication types

MeSH terms

LinkOut - more resources